Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $48.5000 (-2.81%) ($48.5000 - $49.9000) on Wed. May. 7, 2014. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.09% (three month average) | RSI | 23 | Latest Price | $48.5000(-2.81%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -0.6% a day on average for past five trading days. | Weekly Trend | CAPR declines -11.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) JNK(7%) PEJ(7%) VT(7%) XLF(7%) EWG(6%) | Factors Impacting CAPR price | CAPR will decline at least -2.545% in a week (0% probabilities). TLT(-3%) UUP(-2%) SHY(-2%) DIA(-2%) SLV(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.545% (StdDev 5.09%) | Hourly BBV | 0 () | Intraday Trend | -1% | | | |
|
1 - 5 Day Possible Target | $28.4(-41.44%) | Resistance Level | $56.51 | 5 Day Moving Average | $47.7(1.68%) | 10 Day Moving Average | $50.95(-4.81%) | 20 Day Moving Average | $56.51(-14.17%) | To recent high | -59.9% | To recent low | 7.5% | Market Cap | $955m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |